Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesisTeresa L. Ramos, Fermín Sánchez‐Guijo|PLoS ONE|2017Cited by 26
HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?Teresa Lopes Ramos, Fermín Sánchez‐Guijo|Oncotarget|2017Cited by 12